Interestingly, a recent meta-analysis revealed that IFN nonresponders exhibited a decreased risk of HCC recurrence after curative treatment of HCC, compared with no treatment patients, thus indicating that reduced necroinflammation and an inhibition of hepatic fibrosis progression prevent the development of HCC [21]. Here, IFNA1 is linked to hepatocellular carcinoma.